Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2024 |
Summary of Significant Accounting Policies |
|
Schedule of company’s revenue disaggregated by category and source |
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30, |
|
|
|
2024
|
|
|
2023
|
|
|
2024 |
|
|
2023 |
|
|
|
(in thousands)
|
|
|
(in thousands) |
|
Commercial |
|
$ |
1,084 |
|
|
$ |
945 |
|
|
$ |
3,225 |
|
|
$ |
2,565 |
|
Government contracts |
|
|
523 |
|
|
|
5
|
|
|
|
533 |
|
|
|
15 |
|
Equipment sales |
|
|
— |
|
|
|
77 |
|
|
|
— |
|
|
|
77 |
|
Total revenue |
|
$ |
1,607
|
|
|
$ |
1,027 |
|
|
$ |
3,758 |
|
|
$ |
2,657 |
|
|
Schedule of stock-based compensation included in cost of goods sold, research and development, and selling, general and administrative expenses |
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30, |
|
|
|
2024
|
|
|
2023
|
|
|
2024 |
|
|
2023 |
|
|
|
(in thousands)
|
|
|
(in thousands) |
|
Cost of goods sold |
|
$ |
90 |
|
|
$ |
561 |
|
|
$ |
273 |
|
|
$ |
1,705 |
|
Research and development |
|
|
1,032
|
|
|
|
1,843 |
|
|
|
3,672 |
|
|
|
5,201 |
|
Selling, general and administrative |
|
|
2,144
|
|
|
|
2,003 |
|
|
|
7,217 |
|
|
|
5,737 |
|
Total stock-based compensation expense |
|
$ |
3,266 |
|
|
$ |
4,407
|
|
|
$ |
11,162 |
|
|
$ |
12,643 |
|
|
Schedule of diluted weighted average shares |
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30, |
|
|
|
2024
|
|
|
2023
|
|
|
2024 |
|
|
2023 |
|
|
|
(in thousands, except per share amounts) |
|
|
(in thousands, except per share amounts) |
|
Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders |
|
$ |
(13,609
|
) |
|
$ |
(23,220
|
) |
|
$ |
(69,609 |
) |
|
$ |
(55,339 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares – basic and diluted |
|
|
126,429 |
|
|
|
108,045 |
|
|
|
118,978 |
|
|
|
107,504 |
|
Basic and diluted loss per share |
|
$ |
(0.11 |
) |
|
$ |
(0.21 |
) |
|
$ |
(0.59 |
) |
|
$ |
(0.51 |
) |
|
Schedule of anti-dilutive unvested restricted stock units and unvested restricted stock awards |
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30, |
|
Antidilutive Shares Excluded |
|
2024
|
|
|
2023
|
|
|
2024 |
|
|
2023 |
|
|
|
(in thousands)
|
|
|
(in thousands) |
|
Warrants |
|
|
31,353 |
|
|
|
44,268 |
|
|
|
31,353 |
|
|
|
44,268 |
|
Stock Options |
|
|
4,199 |
|
|
|
3,667 |
|
|
|
4,199 |
|
|
|
3,667 |
|
Unvested Restricted Stock Units |
|
|
5,159 |
|
|
|
3,500 |
|
|
|
5,159 |
|
|
|
3,500 |
|
Unvested Restricted Stock Awards |
|
|
231
|
|
|
|
334 |
|
|
|
231 |
|
|
|
334 |
|
|
Schedule of goodwill activities |
|
|
Nine Months Ended September 30,
|
|
|
|
2024 |
|
|
2023 |
|
|
|
(in thousands)
|
|
Beginning Balance |
|
$ |
17,977 |
|
|
$ |
17,493 |
|
Changes in foreign exchange rates |
|
|
208 |
|
|
|
(159 |
) |
Purchase price adjustment |
|
|
— |
|
|
|
(96 |
) |
Ending Balance |
|
$ |
18,185 |
|
|
$ |
17,238 |
|
|